Status:
COMPLETED
Evaluation of the Novel Use of Gamification With Alternative Goal-setting Experiences
Lead Sponsor:
University of Pennsylvania
Conditions:
Atherosclerotic Cardiovascular Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To use a randomized controlled trial to test the effectiveness of four goal-setting strategies within a gamification intervention to increase physical activity among adults at elevated risk for ASCVD.
Detailed Description
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality in the United States. While increased physical activity can reduce this risk, less than half of adults in the United St...
Eligibility Criteria
Inclusion
- Age 18 years or older;
- ability to read and provide informed consent to participate in the study;
- diagnosis of clinical ASCVD or a 10-year ASCVD risk score ≥ 7.5% calculated according to the 2013 ACC/AHA guidelines;
- Smartphone or tablet compatible with application for the wearable activity tracking device.
Exclusion
- Conditions that would make participation infeasible such as inability to provide informed consent, illiteracy or inability to speak, read, and write English;
- conditions that would make participation unsafe such as pregnancy or being told by a physician not to exercise;
- already enrolled in another study targeting physical activity;
- any other medical conditions or reasons he or she is unable to participate in a physical activity study for 24 weeks;
- baseline step count of 10,000 steps or greater.
Key Trial Info
Start Date :
January 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03749473
Start Date
January 14 2019
End Date
June 1 2020
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States, 19104